InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

AKANDA CORP.

AKAN Clue Score44
United Kingdom Fiscal year ends December CIK 0001888014
$1.76 -1.12% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.76 +252.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 15 Mar 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−0.9Net income−1.4EPS, diluted−0.11Fiscal year 2020Revenue0.0Operating income−1.7Net income−2.3EPS, diluted−0.18Fiscal year 2021Revenue0.0 +1,909.3%Operating income−2.6Net income−8.1EPS, diluted−0.50Fiscal year 2022Revenue2.6 +6,223.0%Operating income−20.2Net income−11.7EPS, diluted−3.86Fiscal year 2023Revenue0.4 −83.8%Operating income−3.7Net income−32.3EPS, diluted−573.11Fiscal year 2024Revenue0.8 +97.5%Operating income−4.4Net income−4.1EPS, diluted−3.93
FY2019FY2020FY2021FY2022FY2023FY2024
Revenue n/a 0.0 0.0 2.6 0.4 0.8
Growth +1,909.3% +6,223.0% −83.8% +97.5%
Operating income −0.9 −1.7 −2.6 −20.2 −3.7 −4.4
Net income −1.4 −2.3 −8.1 −11.7 −32.3 −4.1
Growth
EPS, diluted −0.11 −0.18 −0.50 −3.86 −573.11 −3.93

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Fiscal year 2020Gross margin−2,821.3%Operating margin−80,781.0%Net margin−111,569.9%Fiscal year 2021Gross margin−3.8%Operating margin−6,203.4%Net margin−19,625.9%Free cash flow margin−17,217.9%Fiscal year 2022Gross margin124.8%Operating margin−770.2%Net margin−445.0%Free cash flow margin−449.7%Fiscal year 2023Gross margin14.0%Operating margin−863.6%Net margin−7,617.7%Free cash flow margin−354.5%Fiscal year 2024Gross margin24.9%Operating margin−523.8%Net margin−489.6%Free cash flow margin−726.5%
FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin n/a −2,821.3% −3.8% 124.8% 14.0% 24.9%
Operating margin n/a −80,781.0% −6,203.4% −770.2% −863.6% −523.8%
Net margin n/a −111,569.9% −19,625.9% −445.0% −7,617.7% −489.6%
Free cash flow margin n/a n/a −17,217.9% −449.7% −354.5% −726.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Capital expenditure−0.7Fiscal year 2020Capital expenditure−0.4Fiscal year 2021Operating cash flow−6.6Capital expenditure−0.6Free cash flow−7.1Fiscal year 2022Operating cash flow−11.5Capital expenditure−0.3Free cash flow−11.8Fiscal year 2023Operating cash flow−1.5Capital expenditure−0.0Free cash flow−1.5Fiscal year 2024Operating cash flow−4.0Capital expenditure−2.1Free cash flow−6.1
FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow n/a n/a −6.6 −11.5 −1.5 −4.0
Capital expenditure −0.7 −0.4 −0.6 −0.3 −0.0 −2.1
Free cash flow n/a n/a −7.1 −11.8 −1.5 −6.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash0.8Shareholders’ equity−2.9Fiscal year 2020Cash0.0Shareholders’ equity−5.0Fiscal year 2021Cash3.5Shareholders’ equity−2.2Fiscal year 2022Cash0.3Total debt2.6Net cash (debt)−2.4Shareholders’ equity26.9Debt to equity0.10Fiscal year 2023Cash0.1Total debt2.5Net cash (debt)−2.4Shareholders’ equity−3.8Fiscal year 2024Cash3.8Shareholders’ equity4.3
FY2019FY2020FY2021FY2022FY2023FY2024
Cash 0.8 0.0 3.5 0.3 0.1 3.8
Total debt n/a n/a n/a 2.6 2.5 n/a
Net cash (debt) n/a n/a n/a −2.4 −2.4 n/a
Shareholders’ equity −2.9 −5.0 −2.2 26.9 −3.8 4.3
Debt to equity n/a n/a n/a 0.10 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024
Revenue and profit
n/a 0.0 0.0 2.6 0.4 0.8
Growth +1,909.3% +6,223.0% −83.8% +97.5%
n/a 0.0 0.0 0.6 0.4 0.6
n/a −0.1 −0.0 3.3 0.1 0.2
Growth −98.2% +251.2%
0.2 0.2 0.2 3.4 0.3 1.3
−0.9 −1.7 −2.6 −20.2 −3.7 −4.4
Growth
−1.4 −2.3 −8.1 −11.7 −32.3 −4.1
Growth
Per share
−0.11 −0.18 −0.50 −3.86 −573.11 −3.93
−0.11 −0.18 −0.50 −3.86 −573.11 −3.93
Growth
13.1 13.1 16.2 3.0 0.1 1.0
13.1 13.1 16.2 3.0 0.1 1.0
Growth +0.0% +23.6% −81.6% −98.1% +1,750.3%

† The diluted share count jumps at 2022 and 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 6 of 6 years on file.